Pharmacology and Metabolism of Renzapride: A Novel Therapeutic Agent for the

Author： Meyers Nicholas L.   Hickling Roger I.  

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.9, Iss.1, 2008-01, pp. : 37-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological profile of ramosetron, a novel therapeutic agent for IBS

By Hirata T.   Funatsu T.   Keto Y.   Nakata M.   Sasamata M.  

Inflammopharmacology, Vol. 15, Iss. 1, 2007-02 ,pp. : 5-9

Springer Publishing Company

Access to resources Recommend Favorite

The Cardiovascular Safety Profile of Renzapride, a Novel Treatment for Irritable Bowel Syndrome

By Meyers NL   Hickling RI  

The Journal of International Medical Research, Vol. 35, Iss. 6, 2007-11 ,pp. : 848-866

Field House Publishing

Access to resources Recommend Favorite

Novel and Emerging Drugs for Acute Myeloid Leukemia: Pharmacology and Therapeutic Activity

By  

Current Medicinal Chemistry, Vol. 18, Iss. 5, 2011-02 ,pp. : 638-666

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Atypical Antipsychotics: Metabolism and Therapeutic Drug Monitoring (TDM)

By  

Current Drug Metabolism, Vol. 16, Iss. 2, 2015-01 ,pp. : 141-151

Bentham Science Publishers

Access to resources Recommend Favorite

Agent‐Based Modeling in Systems Pharmacology

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 11, 2015-11 ,pp. : 615-629

John Wiley & Sons Inc

Access to resources Recommend Favorite